These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30764677)

  • 21. Association between RASSF1A promoter methylation and renal cell cancer susceptibility: a meta-analysis.
    Huang YQ; Guan H; Liu CH; Liu DC; Xu B; Jiang L; Lin ZX; Chen M
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential of RASSF1A promoter methylation as a biomarker for colorectal cancer: Meta-analysis and TCGA analysis.
    Hu F; Chen L; Bi MY; Zheng L; He JX; Huang YZ; Zhang Y; Zhang XL; Guo Q; Luo Y; Tang WR; Sheng MM
    Pathol Res Pract; 2020 Aug; 216(8):153009. PubMed ID: 32703486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation of RASSF1A and CDH13 genes in individualized chemotherapy for patients with non-small cell lung cancer.
    Zhai X; Li SJ
    Asian Pac J Cancer Prev; 2014; 15(12):4925-8. PubMed ID: 24998565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis.
    Lou-Qian Z; Rong Y; Ming L; Xin Y; Feng J; Lin X
    PLoS One; 2013; 8(1):e54970. PubMed ID: 23372805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis.
    Shi DT; Han M; Gao N; Tian W; Chen W
    Tumour Biol; 2014 Feb; 35(2):943-8. PubMed ID: 23982879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between Ras association domain family 1A promoter methylation and esophageal squamous cell carcinoma: a meta-analysis.
    Yang JZ; Ji AF; Wang JS; Chen ZY; Wen SW
    Asian Pac J Cancer Prev; 2014; 15(9):3921-5. PubMed ID: 24935575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer.
    Kim DH; Kim JS; Ji YI; Shim YM; Kim H; Han J; Park J
    Cancer Res; 2003 Jul; 63(13):3743-6. PubMed ID: 12839968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer.
    Li J; Zhang Z; Dai Z; Popkie AP; Plass C; Morrison C; Wang Y; You M
    Neoplasia; 2003; 5(4):362-6. PubMed ID: 14511407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studies.
    Li YS; Xie Q; Yang DY; Zheng Y
    Mol Biol Rep; 2014 Jun; 41(6):3925-33. PubMed ID: 24566681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of RAS association domain family Protein1A (RASSF1A) methylation states and bladder cancer risk: a systematic review and meta-analysis.
    Gao T; Wang S; He B; Pan Y; Song G; Gu L; Chen L; Nie Z; Xu Y; Li R
    PLoS One; 2012; 7(11):e48300. PubMed ID: 23139773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy.
    Sun X; Yuan W; Hao F; Zhuang W
    Med Sci Monit; 2017 Nov; 23():5389-5395. PubMed ID: 29128865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter methylation of the RASSF1A gene may contribute to colorectal cancer susceptibility: a meta-analysis of cohort studies.
    Wang HL; Liu P; Zhou PY; Zhang Y
    Ann Hum Genet; 2014 May; 78(3):208-16. PubMed ID: 24621386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA).
    Zhan L; Zhang B; Tan Y; Yang C; Huang C; Wu Q; Zhang Y; Chen X; Zhou M; Shu A
    Medicine (Baltimore); 2017 Feb; 96(7):e6097. PubMed ID: 28207521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between
    Markulin D; Vojta A; Samaržija I; Gamulin M; Bečeheli I; Jukić I; Maglov Č; Zoldoš V; Fučić A
    Cancer Genomics Proteomics; 2017; 14(5):363-372. PubMed ID: 28871003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter methylations of RASSF1A and p16 is associated with clinicopathological features in lung cancers.
    Han JC; Xu F; Chen N; Qi GB; Wei YJ; Li HB; Zhang YJ; Li JH; Wang XL; Xu W; Li XF; Jin LF; Jia JY; Ma ZS
    J Cancer Res Ther; 2016; 12(1):340-9. PubMed ID: 27072261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of RASSF1A promoter methylation in the pathogenesis of ovarian cancer: a meta-analysis.
    Si JG; Su YY; Han YH; Chen RH
    Genet Test Mol Biomarkers; 2014 Jun; 18(6):394-402. PubMed ID: 24665911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Delta DNMT3B variants and its association with promoter methylation of p16 and RASSF1A in primary non-small cell lung cancer.
    Wang J; Walsh G; Liu DD; Lee JJ; Mao L
    Cancer Res; 2006 Sep; 66(17):8361-6. PubMed ID: 16951144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA.
    Giannopoulou L; Chebouti I; Pavlakis K; Kasimir-Bauer S; Lianidou ES
    Oncotarget; 2017 Mar; 8(13):21429-21443. PubMed ID: 28206954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between RAS Association Domain Family Protein 1A Promoter Methylation and the Clinicopathological Characteristics in Patients with Ovarian Cancer: A Systematic Meta-Analysis.
    Wang H; Cui M; Zhang S; He J; Song L; Chen Y
    Gynecol Obstet Invest; 2018; 83(4):349-357. PubMed ID: 29130987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.